Last updated: March 2026
Methenolone (Primobolan) is a DHT-derived anabolic steroid available as an injectable enanthate ester and an oral acetate form. This educational reference covers its pharmacology, enanthate vs acetate comparison, documented immune system effects from AIDS wasting studies, and counterfeit prevalence for harm reduction.
Methenolone is a DHT derivative with a 1-methyl group and an added double bond between C1 and C2, which slows hepatic metabolism and provides mild but direct anabolic activity. It does not aromatize and has low androgenic potency.
Methenolone binds androgen receptors directly with moderate affinity. Unlike many AAS, it does not require conversion to a more potent metabolite. Its anabolic effects are modest but clean — genuine lean tissue retention rather than water-laden mass. The 1-methyl addition reduces hepatic breakdown while the DHT backbone prevents aromatization entirely.
Primobolan Enanthate (injectable) is NOT 17α-alkylated — it has minimal hepatotoxicity and a 10–14 day half-life from the enanthate ester. Primobolan Acetate (oral) IS 17α-alkylated and genuinely hepatotoxic. The injectable form is significantly safer on liver health. Oral Primobolan requires much higher doses for comparable effect and carries real liver burden.
Methenolone was studied in HIV/AIDS wasting in the late 1980s–1990s, where researchers noted preserved immune parameters alongside lean mass retention. Some data suggested beneficial effects on CD4 lymphocyte preservation, though mechanistic pathways remain unclear. This remains one of the few AAS with documented immune-adjacent data beyond simple anabolic effects.
Primobolan suppresses the hypothalamic-pituitary-testicular axis more mildly than most other AAS, particularly at lower doses. LH and FSH are reduced but endogenous testosterone doesn't drop as dramatically as with heavier androgens. Despite this, PCT with SERMs is still standard after cycles exceeding 8–10 weeks — "mild suppression" still means suppressed.
Data from published studies on methenolone — including AIDS wasting research, anabolic profiling, and pharmacological assessments of both forms.
Even the mildest AAS requires bloodwork and monitoring. Injectable Primobolan is easier on the liver, but cardiovascular and hormonal risks remain real.
Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.
This page is for educational and harm reduction purposes only. It is not medical advice. Methenolone (Primobolan) is a Schedule III controlled substance in the United States under the Anabolic Steroid Control Act of 1990. Possession, distribution, or use without a valid prescription is illegal and carries serious legal penalties. Anabolic steroids carry significant health risks including liver damage, cardiovascular disease, and hormonal disruption. Always consult a qualified physician before making any decisions regarding hormone use. MeetPeptide does not endorse or encourage the use of controlled substances.